Metraipolis › archive › dc_fb53ea2a6d9c
Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis — Europe PMC PMID:41487575
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41487575
- DOI
- 10.3389/fonc.2025.1690984
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T12:42:45.554Z
- SHA-256 of the archived text
ea628f3c2526e775172cd2b82ef321d65ae10dd14b11ae2a31a0a8c4b8d5e791- Stable URL of this page
https://metraipolis.com/documento/dc_fb53ea2a6d9c
How to cite
Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis — Europe PMC PMID:41487575 — Europe PMC (en), https://europepmc.org/article/MED/41487575 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb53ea2a6d9c (Metraipolis archive dc_fb53ea2a6d9c, sha256 ea628f3c2526e775172cd2b82ef321d65ae10dd14b11ae2a31a0a8c4b8d5e791)
BibTeX
@misc{dcfb53ea2a6d9c,
title = {Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis — Europe PMC PMID:41487575},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41487575},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb53ea2a6d9c; sha256 ea628f3c2526e775172cd2b82ef321d65ae10dd14b11ae2a31a0a8c4b8d5e791},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41487575. Agents can read the archived copy with the MCP tool read_document.